JWH-249

JWH-249 is a synthetic cannabinoid from the naphthoylindole family, which acts as a full agonist at both the CB₁ and CB₂ cannabinoid receptors, but with moderate selectivity for CB₁. It was discovered by and named after Dr. John W. Huffman.

Chemistry

JWH-249 is part of the naphthoylindole family of synthetic cannabinoids. It is structurally related to other synthetic cannabinoids including JWH-018, JWH-073, and JWH-200. JWH-249 is a full agonist at both the CB₁ and CB₂ cannabinoid receptors, with a moderate selectivity for CB₁.

Pharmacology

As a full agonist at the CB₁ and CB₂ receptors, JWH-249 can produce a wide range of effects similar to those of cannabis. These effects can include relaxation, euphoria, and altered perception. However, due to its synthetic nature and the lack of knowledge about its long-term effects, use of JWH-249 can also potentially lead to adverse effects.

Legal Status

The legal status of JWH-249 varies by country and region. In some places, it is classified as a controlled substance due to its potential for abuse and the lack of knowledge about its long-term effects.

See Also

• Synthetic cannabinoids
• Cannabinoid receptor
• JWH-018
• JWH-073
• JWH-200

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia